Lapatinib Ditosylate Monohydrate
Generic Name: lapatinib ditosylate monohydrate
Dosage form: POWDER. Active ingredients: LAPATINIB DITOSYLATE (1 g/g). Category: BULK INGREDIENT.
Overview
Dosage form: POWDER. Active ingredients: LAPATINIB DITOSYLATE (1 g/g). Category: BULK INGREDIENT.
Dosage
Available as powder.
Related Medications
Trastuzumab And Hyaluronidase-oysk
trastuzumab and hyaluronidase-oysk
Endoglycosidase [EPC]
11 DESCRIPTION HERCEPTIN HYLECTA is a combination of trastuzumab and hyaluronidase. Trastuzumab is a humanized IgG1 kappa monoclonal antibody that selectively binds with high affinity to the extracellular domain of the human epidermal growth factor receptor 2 protein, HER2. Trastuzumab is produced by recombinant DNA technology in a mammalian cell (Chinese Hamster Ovary) culture. Trastuzumab has a molecular weight of approximately 148 kDa.
Toxicodendron Pubescens Leaf
toxicodendron pubescens leaf
USES To relieve the symptoms of conditions produced by Poison Oak and Poison Ivy
Estradiol/norethindrone Acetate Transdermal System
estradiol/norethindrone acetate transdermal system
Estrogen [EPC]
DESCRIPTION CombiPatch ® (estradiol/norethindrone acetate transdermal system) is an adhesive-based matrix transdermal patch designed to release both estradiol, an estrogen, and norethindrone acetate (NETA), a progestational agent, continuously upon application to intact skin. Two systems are available, providing the following in vivo delivery rates of estradiol and NETA. 1 NETA=norethindrone acetate.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.